Home
Products
Reagents for Polymerization
Polymerization Catalysts
Cross-Coupling Reaction Catalyst
4-(P-TOLUENESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER, 97%

4-(P-TOLUENESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER, 97%

Name: 4-(P-TOLUENESULFONYLAMINO)PHENYLBORONIC ACID PINACOL ESTER, 97%
Brand: BOC Sciences
Rating: 5 (1 reviews)

Inquiry

Molecular Formula:

C19H24BNO4S

CAS Number:

674776-54-6

Catalog Number:

674776-54-6

Product Information

Molecular Formula:

C19H24BNO4S

Description

4-(p-Toluenesulfonylamino)phenylboronic acid pinacol ester, 97% is a highly purified compound predominantly used in biomedicine. Its exceptional chemical properties make it an effective tool in the development of drugs for treating various diseases, including cancer and inflammation.

Synonyms

4-(p-Toluenesulfonylamino)phenylboronic acid pinacol ester, N-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-p-toluenesulfonamide

IUPAC Name

4-methyl-N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide

Canonical SMILES

B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)C

InChI

InChI=1S/C19H24BNO4S/c1-14-6-12-17(13-7-14)26(22,23)21-16-10-8-15(9-11-16)20-24-18(2,3)19(4,5)25-20/h6-13,21H,1-5H3

InChI Key

RLVWYHYMSBRBKK-UHFFFAOYSA-N

Flash Point

Not applicable

Purity

97%

Safety Information

Hazards

H413

Computed Properties

Hydrogen Bond Donor Count

Hydrogen Bond Acceptor Count

Rotatable Bond Count

Exact Mass

373.1519096 g/mol

Monoisotopic Mass

373.1519096 g/mol

Topological Polar Surface Area

73Å²

Heavy Atom Count

Formal Charge

Complexity

569

Isotope Atom Count

Defined Atom Stereocenter Count

Undefined Atom Stereocenter Count

Defined Bond Stereocenter Count

Undefined Bond Stereocenter Count

Covalently-Bonded Unit Count

Compound Is Canonicalized

Yes

Patents

Publication Number	Title	Priority Date
AU-2013312477-A1	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
AU-2013312477-B2	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
EP-2892534-A2	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
JP-2015529224-A	Compounds and methods for modulating kinases and indicators thereof	2012-09-06
JP-6318156-B2	Compounds and methods for modulating kinases and indicators thereof	2012-09-06
US-10227357-B2	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
US-2014128390-A1	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
WO-2014039714-A2	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
EP-2892534-B1	Compounds and methods for kinase modulation, and indications therefor	2012-09-06
EP-2654752-A1	Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans	2010-12-22